Literature DB >> 17570113

The molecular basis of the pathogenicity of the Dutch highly pathogenic human influenza A H7N7 viruses.

Vincent J Munster1, Emmie de Wit, Debby van Riel, Walter E P Beyer, Guus F Rimmelzwaan, Albert D M E Osterhaus, Thijs Kuiken, Ron A M Fouchier.   

Abstract

During the highly pathogenic avian influenza (HPAI) H7N7 virus outbreak in The Netherlands in 2003, 88 infected persons suffered from mild illnesses, and 1 died of pneumonia. Here, we studied which of the 14 amino acid substitutions observed between the fatal case (FC) virus and a conjunctivitis case (CC) virus determined the differences in virus pathogenicity. In virus-attachment experiments, the CC and FC viruses revealed marked differences in binding to the lower respiratory tract of humans. In a mouse model, the hemagglutinin (HA) gene of the FC virus was a determinant of virus tissue distribution. The lysine at position 627 of basic polymerase 2 (PB2) of the FC virus was the major determinant of pathogenicity and tissue distribution. Thus, remarkable similarities were revealed between recent HPAI H5N1 and H7N7 viruses. We conclude that the influenza virus HA and PB2 genes should be the prime targets for molecular surveillance during outbreaks of zoonotic HPAI viruses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17570113     DOI: 10.1086/518792

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  78 in total

1.  Combination of PB2 271A and SR polymorphism at positions 590/591 is critical for viral replication and virulence of swine influenza virus in cultured cells and in vivo.

Authors:  Qinfang Liu; Chuanling Qiao; Henju Marjuki; Bhupinder Bawa; Jingqun Ma; Stephane Guillossou; Richard J Webby; Jürgen A Richt; Wenjun Ma
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Virology: Host protein clips bird flu's wings in mammals.

Authors:  Anice C Lowen
Journal:  Nature       Date:  2016-01-07       Impact factor: 49.962

3.  NP, PB1, and PB2 viral genes contribute to altered replication of H5N1 avian influenza viruses in chickens.

Authors:  Jamie L Wasilenko; Chang Won Lee; Luciana Sarmento; Erica Spackman; Darrell R Kapczynski; David L Suarez; Mary J Pantin-Jackwood
Journal:  J Virol       Date:  2008-02-27       Impact factor: 5.103

4.  An inhibitory activity in human cells restricts the function of an avian-like influenza virus polymerase.

Authors:  Andrew Mehle; Jennifer A Doudna
Journal:  Cell Host Microbe       Date:  2008-08-14       Impact factor: 21.023

5.  Mammalian adaptation in the PB2 gene of avian H5N1 influenza virus.

Authors:  Ji-Young Min; Celia Santos; Adam Fitch; Alan Twaddle; Yoshiko Toyoda; Jay V DePasse; Elodie Ghedin; Kanta Subbarao
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

6.  Highly sensitive real-time in vivo imaging of an influenza reporter virus reveals dynamics of replication and spread.

Authors:  Vy Tran; Lindsey A Moser; Daniel S Poole; Andrew Mehle
Journal:  J Virol       Date:  2013-10-02       Impact factor: 5.103

7.  Amino acid substitutions in polymerase basic protein 2 gene contribute to the pathogenicity of the novel A/H7N9 influenza virus in mammalian hosts.

Authors:  Chris Ka Pun Mok; Horace Hok Yeung Lee; Maxime Lestra; John Malcolm Nicholls; Michael Chi Wai Chan; Sin Fun Sia; Huachen Zhu; Leo Lit Man Poon; Yi Guan; Joseph Sriyal Malik Peiris
Journal:  J Virol       Date:  2014-01-08       Impact factor: 5.103

Review 8.  Pathogenicity of highly pathogenic avian influenza virus in mammals.

Authors:  Emmie de Wit; Yoshihiro Kawaoka; Menno D de Jong; Ron A M Fouchier
Journal:  Vaccine       Date:  2008-09-12       Impact factor: 3.641

Review 9.  H5N1 pathogenesis studies in mammalian models.

Authors:  Jessica A Belser; Terrence M Tumpey
Journal:  Virus Res       Date:  2013-02-28       Impact factor: 3.303

Review 10.  Emerging influenza.

Authors:  Emmie de Wit; Ron A M Fouchier
Journal:  J Clin Virol       Date:  2008-01       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.